LEARN: Breast cancer and HRT

The use of hormone replacement therapy (HRT) in individuals with a history of breast cancer is complex, as breast cancer is often hormone-sensitive, and there is concern that HRT could increase the risk of recurrence


Risk Assessment:

• Individualized Approach: Decisions should consider the type of breast cancer, time since diagnosis, other risk factors (e.g., BRCA mutations), and the severity of menopausal symptoms.

• Non-Hormonal Alternatives: First-line management typically includes non-hormonal treatments for menopausal symptoms, such as SSRIs/SNRIs, gabapentin, or cognitive behavioral therapy (CBT), to avoid potential risks.


HRT can be prescribed after breast cancer, but it depends on the individual and cannot be generalised.  At FGP we try to prioritise appointment for wāhine and whānau who going through, or who have experienced breast cancer because we believe on supporting you as a whole person, and not defining you by your breast cancer. 

Share by: